The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free surviva…

Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more

~Estimated

~$10 – $6,250

St. Jude Children's Research HospitalNCT06239272

Phase 2

SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

This is a non-randomized, open label, single arm Phase II trial with a two-stage design with histologically-confirmed metastatic and/or recurrent epithelioid h…

Epithelioid Hemangioendothelioma (EHE)

~Estimated

~$10 – $7,500

Sarcoma Alliance for Research through CollaborationNCT07104331

Phase 1

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BGC515 Capsules in Patients With Advanced Solid Tumors

The goal of this open-label, dose escalation and dose expansion Phase I clinical trial is to evaluate the safety, tolerability, pharmacokinetics and preliminar…

MesotheliomaEpithelioid Hemangioendothelioma(EHE)Solid Tumor

~Estimated

~$10 – $8,750

BridGene Biosciences Inc.NCT06452160